Drugs News and Research

RSS

MEDNET partners with Axius Healthcare Group to distribute MedSafe

What's the cost of saving a teenage life? When it comes to preventing accidental death resulting from prescription medication abuse, there's no price tag. Parents with good intentions, however, may be unaware that the lock-boxes they've installed are not protecting their teens from the ticking timebomb of prescription drugs.

21 Oct 2009

FDA grants Fast Track designation for MacuSight's Perceiva

MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).

21 Oct 2009

Life science tool companies must consider multiple factors to develop strategies for future

Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

Comparative Effectiveness Research: One way to beat the competition

A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information.

21 Oct 2009

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

21 Oct 2009

Palmerolide A: Real hope for cancer treatment

A targeted chemotherapy for the treatment of skin cancer is one step closer, after a team of University of Alberta researchers successfully synthesized a natural substance that shows exceptional potential to specifically treat this often fatal disease.

21 Oct 2009

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

Physicists, chemists and engineers at the University of Pennsylvania have demonstrated a novel method for the controlled formation of patchy particles, using charged, self-assembling molecules that may one day serve as drug-delivery vehicles to combat disease and perhaps be used in small batteries that store and release charge.

21 Oct 2009

D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper

D2 Pharma Consulting LLC (D2) is a best-in-class national consulting company that works with pharmaceutical and biotech manufacturers on the implementation of REMS compliant distribution programs, in addition to other commercialization activities. D2 structures REMS distribution programs on behalf of their clients that leverage supply chain efficiencies while complying with FDA mandates.

21 Oct 2009

UF scientists shed new light on old medical procedure

You might not know what it's called, but if you've had general anesthesia before surgery, especially after an accident, it is likely you have received Sellick's maneuver. That's when fingers are pressed against a patient's throat to prevent regurgitation and spilling of stomach contents into the airway and lungs while anesthesia is being administered.

21 Oct 2009

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

Dr. Drew Pinsky, a nationally renowned drug abuse expert, and the Five Moms, five exceptional women dedicated to spreading the word about the dangers of cough medicine abuse, are speaking out to educate parents and congressional staff on Capitol Hill about the issue of over-the-counter (OTC) cough medicine abuse among teens and how to prevent it through education.

21 Oct 2009

Research shows exon-skipping drug may prove effective for treating Duchenne muscular dystrophy

An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

21 Oct 2009

Logical Therapeutics to present its clinical study results on LT-NS001

Logical Therapeutics, Inc. (Logical), a biopharmaceutical company focused on developing products that treat medical conditions associated with inflammation, has been selected to present the results of its clinical study comparing the gastrointestinal (GI) safety of its lead product LT-NS001, vs. naproxen at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009.

21 Oct 2009

Rural doctors, administrators push for health reform to include safeguards against Rx drug abuse

An increase in prescription drug fraud has caused doctors and hospital administrators to call for legislation to provide stronger safeguards. They say that such measures are especially important to protect government programs such as Medicaid and that heath reform proposals should increase coverage for drug treatment and rehabilitation. They note that prescription drug abuse and Medicaid fraud are especially sensitive issues in rural areas that struggle to attract providers.

21 Oct 2009

Swine flu treatments, safety issues prompt health workers to speak out

In anticipation of new swine flu cases, medical workers are looking for new ways help their patients - and protect themselves.

21 Oct 2009

Osteologix to continue clinical development of NB S101 osteoporosis drug

Osteologix, Inc., a bio-pharmaceutical company announced today that the company will continue the clinical development for its osteoporosis drug, NB S101 (strontium malonate), in the United States and the rest of the world markets. Additionally, the company wants to recognize World Osteoporosis Day’s significance and make more people aware of its research dedicated to improving the lives of people with osteoporosis.

21 Oct 2009

Rice University scientists win NIH stimulus funds to study influenza A

Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu.

21 Oct 2009

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

A cholera outbreak in Zimbabwe has infected more than 100, resulting in five deaths, state media said Tuesday, Reuters reports, "raising fears of a repeat of last year's epidemic that claimed more than 4,000 lives.

21 Oct 2009

Patients with chronic hepatitis C can benefit by drinking coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).

20 Oct 2009

Targacept presents data from Phase 2b clinical trial of TC-5214

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.

20 Oct 2009

Drugs News and Research

MEDNET partners with Axius Healthcare Group to distribute MedSafe

FDA grants Fast Track designation for MacuSight's Perceiva

Life science tool companies must consider multiple factors to develop strategies for future

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Comparative Effectiveness Research: One way to beat the competition

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Palmerolide A: Real hope for cancer treatment

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

D2 Pharma Consulting develops "REMS Challenges and Real World Solutions" White Paper

UF scientists shed new light on old medical procedure

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

Research shows exon-skipping drug may prove effective for treating Duchenne muscular dystrophy

Logical Therapeutics to present its clinical study results on LT-NS001

Rural doctors, administrators push for health reform to include safeguards against Rx drug abuse

Swine flu treatments, safety issues prompt health workers to speak out

Osteologix to continue clinical development of NB S101 osteoporosis drug

Rice University scientists win NIH stimulus funds to study influenza A

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

Patients with chronic hepatitis C can benefit by drinking coffee

Targacept presents data from Phase 2b clinical trial of TC-5214

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News